Lantheus Holdings (LNTH) EBITDA Margin Growth (3y) (2017 - 2026)
Lantheus Holdings (LNTH) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.67 Bn | 34.93 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 30.59 Bn | 28.65 Bn | 1.62 Bn | -37.00 |
| 3 | RedHill Biopharma | 26.22 Bn | 26.22 Bn | - | - |
| 4 | United Therapeutics | 23.80 Bn | 21.65 Bn | 648.10 Mn | -1,442.00 |
| 5 | Curaleaf Holdings | 23.70 Bn | 23.70 Bn | 157.29 Mn | - |
| 6 | Viatris | 18.69 Bn | 16.89 Bn | 1.16 Bn | -1,299.00 |
| 7 | Neurocrine Biosciences | 16.86 Bn | 15.54 Bn | 800.70 Mn | 3,972.00 |
| 8 | Elanco Animal Health | 11.99 Bn | 11.57 Bn | 785.00 Mn | 5,310.00 |
| 9 | Dr Reddys Laboratories | 11.65 Bn | 11.51 Bn | - | - |
| 10 | Lantheus Holdings | 78.78 Mn | -419.80 Mn | 230.92 Mn | 2,466.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,466.00 |
| Dec 31, 2025 | 8,421.00 |
| Sep 30, 2025 | -2,447.00 |
| Jun 30, 2025 | -498.00 |
| Mar 31, 2025 | -83.00 |
| Dec 31, 2024 | -3,731.00 |
| Sep 30, 2024 | 4,935.00 |
| Jun 30, 2024 | 5,257.00 |
| Mar 31, 2024 | 1,194.00 |
| Dec 31, 2023 | -93,849.00 |
| Sep 30, 2023 | 4,105.00 |
| Jun 30, 2023 | 4,699.00 |
| Mar 31, 2023 | -1,096.00 |
| Dec 31, 2022 | -7,916.00 |
| Sep 30, 2022 | 2,590.00 |
| Jun 30, 2022 | 1,129.00 |
| Mar 31, 2022 | 952.00 |
| Dec 31, 2021 | -4,691.00 |
| Sep 30, 2021 | -3,258.00 |
| Jun 30, 2021 | -4,511.00 |